PHAS
PHAS Real Time Price USDRecent trades of PHAS by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by PHAS's directors and management
Government lobbying spending instances
-
$20,000 Oct 16, 2020 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$20,000 Jul 16, 2020 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
Estimated quarterly lobbying spending
PHAS Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to PHAS
Number of mentions of PHAS in WallStreetBets Daily Discussion
Recent picks made for PHAS stock on CNBC
ETFs with the largest estimated holdings in PHAS
|
Shareholder
|
Shares Held
|
|---|
- Who owns $PHAS stock?
- Who owns the most shares of $PHAS stock?
- What funds own $PHAS stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PHAS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.